Gilead Sciences Inc (NASDAQ:GILD)

107.56
Data as of Aug 29
 +0.05 / +0.05%
Today’s Change
58.81
Today|||52-Week Range
108.77
+43.22%
Year-to-Date
Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog
Aug 29 / Zacks.com
3 Drugs Stocks On The Rise
Aug 27 / TheStreet.com
Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog
Aug 29 / Zacks.com
Is It Time to Buy AbbVie Stock?
Aug 27 / MotleyFool.com
Intellipharmaceutics' Oxycodone Program to Prevent Overdose - Analyst Blog
Aug 29 / Zacks.com
Kite Pharma (KITE) Shows Strength: Stock Rises 17.7% - Tale of the Tape
Aug 27 / Zacks.com
Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog
Aug 29 / Zacks.com
Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog
Aug 27 / Zacks.com
Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx - Analyst Blog
Aug 29 / Zacks.com
China Biologic Products, Inc. (CBPO) Rises: Stock Jumps 7.4% - Tale of the Tape
Aug 27 / Zacks.com
What You Need to Know About the Roche-InterMune Deal
Aug 29 / Benzinga
Isis Pharmaceuticals, Inc. (ISIS) Surges: Stock Moves 10.8% Higher - Tale of the Tape
Aug 27 / Zacks.com
Momenta-Sandoz's Generic Copaxone Accepted for Review by FDA - Analyst Blog
Aug 29 / Zacks.com
Celldex Therapeutics (CLDX) Worth Watching: Stock Rises 9.1% - Tale of the Tape
Aug 27 / Zacks.com
Protalix BioTherapeutics, Inc. (PLX) Jumps: Stock Adds 8.3% in Session - Tale of the ...
Aug 29 / Zacks.com
Roche, InterMune a Strategic Play in Midst of Inversions
Aug 27 / TheStreet.com
Why Gilead Sciences (GILD) Could Be Positioned for a Surge? - Tale of the Tape
Aug 29 / Zacks.com
3 Reasons Pfizer Inc.'s Stock Could Fall
Aug 27 / MotleyFool.com
OncoMed Pharmaceuticals (OMED) in Focus: Stock Up 9.9% - Tale of the Tape
Aug 29 / Zacks.com
Achillion Pharmaceuticals (ACHN) Jumps: Stock Adds 9% in Session - Tale of the Tape
Aug 27 / Zacks.com
Has Gilead Sciences, Inc.'s Star Drug Already Peaked?
Aug 28 / MotleyFool.com
After Recent Surge, Are Biotech ETFs Back on Track? - ETF News And Commentary
Aug 27 / Zacks.com
Bristol-Myers' Oral HCV Treatment Daklinza Gets EU Clearance - Analyst Blog
Aug 28 / Zacks.com
#PreMarket Primer: Wednesday, August 27: Israel And Hamas To Resume Peace Talks In Ca...
Aug 27 / Benzinga
RedHill Expands ERADICATE Study on RHB-105 for H. pylori - Analyst Blog
Aug 28 / Zacks.com
Alkermes Gains on Aripiprazole Lauroxil NDA Submission - Analyst Blog
Aug 26 / Zacks.com
Amgen's Chronic Heart Failure Drug Gets Priority Review - Analyst Blog
Aug 28 / Zacks.com
Kite Pharma Drug Fares Well in Non-Hodgkin's Lymphoma Study - Analyst Blog
Aug 26 / Zacks.com
Aegerion Resolves FDA's Warning on Juxtapid, Lifts Overhang - Analyst Blog
Aug 28 / Zacks.com
Cardiome Pharma Signs Agreement with Eurolab for Brinavess - Analyst Blog
Aug 26 / Zacks.com
MediciNova Rises on FDA's Nod on MN-166 Study Initiation - Analyst Blog
Aug 28 / Zacks.com
Jim Cramer's 'Mad Money' Recap: A Monster of an August
Aug 26 / TheStreet.com
Q2 Earnings Season in Rearview Mirror - Earnings Outlook
Aug 28 / Zacks.com
Regado Slumps on Permanent Termination of Revolixys Study - Analyst Blog
Aug 26 / Zacks.com
Allergan Seeks Court Order to Stop Valeant, Affiliates - Analyst Blog
Aug 28 / Zacks.com
VIVUS Acquires Certain Topamax Related Patents from J&J - Analyst Blog
Aug 26 / Zacks.com
BioTime's AST-OPC1 Cleared by FDA for Phase I/IIa Study - Analyst Blog
Aug 28 / Zacks.com
Should Gilead Sciences, inc. Fear This New Competitor Drug?
Aug 26 / MotleyFool.com
Repros Reports Encouraging Late-Stage Data on Androxal - Analyst Blog
Aug 28 / Zacks.com
Stock Market News for August 26, 2014 - Market News
Aug 26 / Zacks.com
Q2 Earnings Season in Rearview Mirror - Earnings Trends
Aug 28 / Zacks.com
Gilead (GILD) Shares March Higher, Can It Continue? - Tale of the Tape
Aug 26 / Zacks.com
Poised for a Smash-Bang 2015
Aug 28 / TheStreet.com
Keryx Biopharmaceuticals (KERX) in Focus: Stock Adds 8.4% in Session - Tale of the Ta...
Aug 26 / Zacks.com
Bristol-Myers Squibb's Daklinza Threatens Johnson & Johnson More Than Gilead Sciences
Aug 28 / MotleyFool.com
TrovaGene (TROV) Jumps: Stock Rises 9.2% - Tale of the Tape
Aug 26 / Zacks.com
Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)
Aug 27 / Benzinga
InterMune (ITMN) Worth Watching: Stock Rises 35.4% - Tale of the Tape
Aug 26 / Zacks.com
3 Stocks That Are Overextended
Aug 27 / Investing Channel
#PreMarket Primer: Tuesday, August 26: US Gathers Intelligence In Syria
Aug 26 / Benzinga

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.